![discount label](https://static.cymitquimica.com/public/img/discount.png)
![No image](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
![Targetmol Targetmol logo](https://static.cymitquimica.com/public/img/partners/targetmol.png)
Ravulizumab
CAS: 1803171-55-2
Ref. TM-T76867
1mg | 235.00 € | ||
5mg | 588.00 € | ||
10mg | 944.00 € | ||
25mg | 1,396.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,547.00 € |
Product Information
- ALXN1210
Ravulizumab (ALXN1210) is a humanized antibody for blocking complement activation, treating PNH, aHUS, and myasthenia gravis.
Chemical properties
Technical inquiry about: TM-T76867 Ravulizumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.